Hedge Fund - Biotechnology Value Fund / BVF Inc
4D Molecular Therapeutics Inc. (FDMT)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $34,719,668 | 1.17% | 4,629,289 | $10.14 |
| 2 | 2025 - Q3 (2025-09-30) | $40,228,521 | 1.63% | 4,629,289 | $5.98 |
| 3 | 2025 - Q2 (2025-06-30) | $17,174,662 | 0.61% | 4,629,289 | $3.52 |
| 4 | 2025 - Q1 (2025-03-31) | $14,732,963 | 0.6% | 4,561,289 | $4.71 |
| 5 | 2024 - Q4 (2024-12-31) | $14,875,476 | 0.5% | 2,670,642 | $7.85 |
| 6 | 2024 - Q3 (2024-09-30) | $79,806,360 | 2.33% | 7,382,642 | $16.60 |
| 7 | 2024 - Q2 (2024-06-30) | $82,331,449 | 2.3% | 3,922,413 | $25.09 |
| 8 | 2024 - Q1 (2024-03-31) | $124,968,078 | 3.43% | 3,922,413 | $25.51 |
| 9 | 2023 - Q4 (2023-12-31) | $81,190,187 | 2.03% | 4,007,413 | $13.16 |
| 10 | 2023 - Q3 (2023-09-30) | $51,014,367 | 1.37% | 4,007,413 | $16.73 |
| 11 | 2023 - Q2 (2023-06-30) | $72,413,953 | 2.01% | 4,007,413 | $18.41 |
| 12 | 2023 - Q1 (2023-03-31) | $68,887,429 | 2.51% | 4,007,413 | $19.45 |
| 13 | 2022 - Q4 (2022-12-31) | $89,004,643 | 3.75% | 4,007,413 | $15.45 |
| 14 | 2022 - Q3 (2022-09-30) | $32,220,000 | 1.33% | 4,007,413 | $9.06 |
| 15 | 2022 - Q2 (2022-06-30) | $27,972,000 | 1.35% | 4,007,413 | $9.72 |
| 16 | 2022 - Q1 (2022-03-31) | $40,288,000 | 1.61% | 2,664,521 | $15.70 |
| 17 | 2021 - Q4 (2021-12-31) | $44,009,000 | 1.59% | 2,005,862 | $24.51 |
| 18 | 2021 - Q3 (2021-09-30) | $54,098,000 | 2.11% | 2,005,862 | $28.52 |
| 19 | 2021 - Q2 (2021-06-30) | $48,301,000 | 1.81% | 2,005,862 | $30.61 |
| 20 | 2021 - Q1 (2021-03-31) | $44,728,000 | 1.67% | 1,031,070 | $44.29 |
| 21 | 2020 - Q4 (2020-12-31) | $45,847,000 | 1.8% | 1,106,070 | $41.28 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center